The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I clinical trial investigating the telomerase vaccine UV1 in combination with pembrolizumab in patients with advanced melanoma.
 
Yousef Zakharia
Consulting or Advisory Role - Amgen; Bayer; Cardinal Health; Castle Biosciences; Clovis Oncology; Eisai; Exelixis; Janssen; Novartis; Pfizer; Roche/Genentech; TTC Oncology
Travel, Accommodations, Expenses - Newlink Genetics
 
Steven O'Day
Honoraria - Bristol-Myers Squibb; Merck
Consulting or Advisory Role - Biothera; Bristol-Myers Squibb; Exicure; ImmunSYS; Merck
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Biothera (Inst); Bristol-Myers Squibb (Inst); Exicure (Inst); Genocea Biosciences (Inst); ImaginAB (Inst); Merck (Inst); Shattuck Labs (Inst); Ultimovacs (Inst); Vyriad (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck
 
Wenche Rasch
Employment - Ultimovacs
Stock and Other Ownership Interests - Ultimovacs
Honoraria - Ultimovacs
 
Mohammed M. Milhem
Honoraria - Array BioPharma; Biontech; Novartis
Consulting or Advisory Role - Array BioPharma; Biontech; Exicure; Novartis
Research Funding - Amgen (Inst); E.R. Squibb Sons, LLC (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Prometheus (Inst)